Wiki Obesity coding for patients being treated with GLP-1 meds

Create Wiki
R

RhondaJBurke

New
Messages
2
Location
Alfred, ME
Best answers
0
Is it appropriate to continue to code morbid obesity for patients who are currently being treated with GLP-1 medications and have a measured reduction in BMI from 40+ to below 35? There continues to be active treatment for the diagnosis with medication, along with routine assessment & monitoring.
 
I think a diagnosis of obesity or morbid obesity still has to be stated in order to code it. However, this leads to another question. If obesity is stated in the HPI, ROS, or exam only, but the plan shows it's being treated in some way, can it be coded? I would think yes.
Example:
Patient presents for followup of elevated BMI.
-Patient has had 6 pound weight loss over the last 2 weeks
-Patient has been able to obtain semaglutide from outside clinic and is currently on 0.25 mg dosing
-Counseled patient on medication including usage and side effects. Patient expressed understanding.

Physical Exam
Constitutional:
Appearance: Normal appearance. She is obese.
Psychiatric:
Mood and Affect: Normal.
Behavior: Behavior normal.

Plan
Elevated BMI 41, counseled on continuing Ozempic at 0.25 mg dosing weekly as this does appear to be having good effect with weight loss.
 
You must log in or register to reply here.
Top